BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

≡

PROGRAM

2025 Innovation Forum Agenda

​​

2025 Innovation Forum Agenda

Date July 23-25, 2025

Venue July 23 Room 701C, 7F, TaiNEX2
July 24-25 Room 401, 4F, TaiNEX1

Day 1 - Wednesday, July 23Room 701C, 7F, TaiNEX2
Day 2 - Thursday, July 24Room 401, 4F, TaiNEX1
Day 3 - Friday, July 25Room 401, 4F, TaiNEX1

14:10 – 15:40

Session A-1 – New Therapeutic Modalities

TBD
14:10 – 14:15

Opening Remarks

  • Han-Chung Wu, Director, Biomedical Translation Research Center (BioTReC), Academia Sinica, Taiwan
14:15 – 14:35

Topic TBC

  • Mohamed EI-Sayed, Chief Scientific Officer, Nucleic Acid Therapeutics Initiative (NATi), A*STAR, Singapore
14:35 – 14:55

Topic TBC

  • Sherry Ku, Founder and President, Good Management Consulting Inc; Consulting Expert, Biomedical Translation Research Center, Academia Sinica
14:55 – 15:15

Topic

  • Christine dela Cruz, Director, Medical Apairs, Therapeutic Expertise, Oncology and Hematologym, ICON Biotech
15:15 – 15:35

Panel Discussion

Moderator:

  • Han-Chung Wu, Director, Biomedical Translation Research Center (BioTReC), Academia Sinica, Taiwan

Panelist:

  • Mohamed EI-Sayed, Chief Scientific Officer, Nucleic Acid Therapeutics Initiative (NATi), A*STAR, Singapore
  • Sherry Ku, Founder and President, Good Management Consulting Inc; Consulting Expert, Biomedical Translation Research Center, Academia Sinica
  • Christine dela Cruz, Director, Medical Apairs, Therapeutic Expertise, Oncology and Hematologym, ICON Biotech
15:35 – 15:40

Closing Remarks

  • Han-Chung Wu, Director, Biomedical Translation Research Center (BioTReC), Academia Sinica, Taiwan

16:00 – 17:30

Session A-2 – Gene and Cell Therapies- Advanced Manufacture and Beyond

TBD
16:00 – 16:05

Opening Remarks

  • David Chang, CEO, Taiwan Bio-Manufacturing Corporation (TBMC)
16:05 – 16:20

Topic TBC

  • Ann Lee, Chief Technical Officer, Prime Medicine
16:20 – 16:35

Overcoming Allogenic Immune Rejection

  • Snehal Patel, Executive Vice President and Chief Technical Officer, Sana Biotechnology
16:35 – 16:50

Opposites Attract: Fast Technology & Deliberate Regulatory: How can manufacturing adapt to meet therapeutic demand?

  • Matthew Hewitt, Vice President, CTO Manufacturing Business Division, Charles River Laboratories
16:50 – 17:05

Topic TBC

  • Jeffrey Chou, Senior Vice President, Clinical Science, Iovance Biotherapeutics
17:25 – 17:30

Panel Discussion

Moderator:

  • David Chang, CEO, Taiwan Bio-Manufacturing Corporation (TBMC)

Panelists:

  • Ann Lee, Chief Technical Officer, Prime Medicine
  • Snehal Patel, Executive Vice President and Chief Technical Officer, Sana Biotechnology
  • Matthew Hewitt, Vice President, CTO Manufacturing Business Division, Charles River Laboratories
  • Jeffrey Chou, Senior Vice President, Clinical Science, Iovance Biotherapeutics

09:00 – 10:30

Session A-3 – AI & Translational Medicine

TBD
09:00 – 09:05

Opening Remarks

  • Huey-Kang Sytwu, President, National Health Research Institutes; Distinguished Investigator, National Institute of Infectious Diseases and Vaccinology, NHRI; Academician, Academia Sinica
09:05 – 09:25

AI-Powered Alignment of High-Content Screening Data: Accelerating Drug Discovery Through Cross-Dataset Learning

  • Lani Wu, Professor, University of California, San Francisco
09:25 – 09:45

Topic TBC

  • Brian Bradbury, Vice President, Center for Observational Research, Amgen
09:45 – 10:05

Topic TBC

  • Feng-Chi Chen, Executive Director, Forum & Deputy Director and Investigator, Institute of Population Health Sciences, National Health Research Institutes
10:05 – 10:30

Panel Discussion

Moderator:

  • Hsing-Pang Hsieh, Director, Institute of Biotechnology and Pharmaceutical Research (IBPR), National Health Research Institutes

Panelists:

  • Lani Wu, Professor, University of California, San Francisco
  • Brian Bradbury, Vice President, Center for Observational Research, Amgen
  • Feng-Chi Chen, Executive Director, Forum & Deputy Director and Investigator, Institute of Population Health Sciences, National Health Research Institutes

10:40 – 12:15

Session A-4 – Taiwan BIO Awards-Successful Stories

TBD
10:40 – 12:15

Sharing the Experience of Biotech Success 2025 Taiwan BO Awards Winners:

- Outstanding Company of the Year

- Emerging Company of the Year

- Startup of the Year

- Innovation of the Year

12:25-13:55

Session A-5 – CMC Program Design: Pioneering Biologics Development Excellence

TBD
12:25 – 12:30

Opening Remarks

  • Bobby Sheng, Chairman & CEO, Bora Pharmaceuticals
12:30 – 12:50

Topic TBC

  • Stephen Lam, CEO, Tanvex
12:50 – 13:10

Topic TBC

  • Jennifer Kuan, Vice President of Taiwan Operations, Bora Pharmaceuticals
13:10 – 13:30

Topic TBC

  • Speaker Inviting, Shine On Bio
13:30 – 13:50

Topic TBC

  • Vu Truong, Founder & CEO, Aridis Pharmaceuticals
13:50 – 13:55

Closing Remarks

  • Bobby Sheng, Chairman & CEO, Bora Pharmaceuticals

14:10 – 15:40

Session A-6 – Innovative Developments and Cross-Disciplinary Applications of Antibody Derivatives

TBD

16:00 – 17:30

Session A-7 – Innovative Developments and Cross-Disciplinary Applications of Antibody Derivatives

TBD

09:00 – 10:30

Session A-8 – Novel ADC-based Target Therapy

TBD
09:00 – 09:05

Opening Remarks

  • Development Center for Biotechnology
09:05 – 09:25

OpenTopic TBC

  • Teiji Wada, Head of Research Platform and Vice President of Research Innovation Planning Department, Daiichi Sankyo
09:25 – 09:45

OpenTopic TBC

  • Yu-Hsun Lo, Director of Protein Engineering Department, Institute of Biologics, Development of Center for Biotechnology
09:45 – 10:05

Topic TBC

  • Luke BI, Executive Director, Head of China BioA and APAC LCMS, Labcorp
10:10 – 10:30

Panel Discussion

Moderator:

  • Development Center for Biotechnology

Panelists:

  • Teiji Wada, Head of Research Platform and Vice President of Research Innovation Planning Department, Daiichi Sankyo
  • Yu-Hsun Lo, Director of Protein Engineering Department, Institute of Biologics, Development of Center for Biotechnology
  • Luke BI, Executive Director, Head of China BioA and APAC LCMS, Labcorp

10:45 – 12:15

Session A-9 – Smart HealthCare

TBD
10:45 – 10:50

Opening Remarks

  • Kang-Yun Lee, Executive Vice President, Taipei Medical University
10:50 – 11:05

Reshaping the Future Healthcare with “Gen” Medicine

  • Ray-Jade Chen, Chairman, Board of Trustees, Taipei Medical University; Chair Professor, Taipei Medical University, Taiwan
11:05 – 11:20

AI Applications in Clinical Practice: Insights from TMU Health System (TBC)

  • Mai-Szu Wu, President, Taipei Medical University
11:20 – 11:35

AI-Driven Cybersecurity in Healthcare Systems (TBC)

  • Wei-Bin Lee, CEO of the Hon Hai Research Institute and the Director of the Information Security Research Center, Hon Hai Technology Group (Foxconn®)
11:35 – 11:50

Regulatory Insights into the Latest FDA Guidelines on Smart Healthcare and AI-Based Medical Devices (TBC)

  • Chia-Hua Maggie Ho, COO, Amarex Taiwan
11:50 – 12:15

Panel Discussion

Moderator:

  • Kang-Yun Lee, Executive Vice President, Taipei Medical University (TBC)

Panelists:

  • Ray-Jade Chen, Chairman, Board of Trustees, Taipei Medical University; Chair Professor, Taipei Medical University, Taiwan
  • Mai-Szu Wu, President, Taipei Medical University
  • Wei-Bin Lee, CEO of the Hon Hai Research Institute and the Director of the Information Security Research Center, Hon Hai Technology Group (Foxconn®)
  • Chia-Hua Maggie Ho, COO, Amarex Taiwan

12:25 – 13:55

Session A-10 – Precision Health

TBD

14:10 – 17:00

Session A-11 – Special Session: Digital Health

TBD
14:10 – 14:20

Opening Remarks

  • Liang-Gee Chen, Chairman, Taiwan Digital Health Industry Development Association
  • Johnsee Lee, Chairman of BIO Asia–Taiwan 2025; Honorary Chairman, Taiwan Bio Industry Organization (Taiwan BIO)
14:20 – 14:40

National-Level Investments in Building the Precision Healthcare Industry

  • Chin-Ching Liu, Minister, National Development Council (Inviting)
14:40 – 15:00

Leveraging Health Big Data to Develop Diverse Smart Healthcare Solutions

  • Chung-Liang Shih, Director General, National Health Insurance Administration, Ministry of Health and Welfare
15:00 – 15:20

Smart Healthcare Cloud Ecosystem: Technology Integration and Future Prospects

  • Barry Lam, Chairman & CEO, Quanta Group (Inviting)
15:20 – 15:35

Topic TBC

  • Amy McDonough, Managing Director, Strategic Health Solutions, Google Health (Inviting)
15:35 – 15:55

5G and IoT-Driven Smart Health Solutions

  • Chee Ching, President, Far EasTone Telecom
15:55 – 16:10

Breakthrough Applications and Challenges of AI in Smart Healthcare

  • Allen Chia En Lien, Chairman and CEO, Acer Medical (Inviting)
16:10 – 16:25

Topic TBC

  • Ed Deng, Co-Founder and CEO, Health2Sync
16:25 – 16:45

Applications of Digital Technology in Enhancing Healthcare Efficiency and Innovation

  • Nick Hung, Executive Vice President of Technology and Transformation, Deloitte Taiwan
16:45 – 17:30

Panel Discussion

Moderator:

  • Liang-Gee Chen, Chairman, Taiwan Digital Health Industry Development Association
  • Johnsee Lee, Chairman of BIO Asia–Taiwan 2025; Honorary Chairman, Taiwan Bio Industry Organization (Taiwan BIO)

Panelists:

  • Chin-Ching Liu, Minister, National Development Council (Inviting)
  • Chung-Liang Shih, Director General, National Health Insurance Administration, Ministry of Health and Welfare
  • Barry Lam, Chairman & CEO, Quanta Group
  • Chee Ching, President, Far EasTone Telecom
  • Allen Chia En Lien, Chairman and CEO, Acer Medical (Inviting)
  • Ed Deng, Co-Founder and CEO, Health2Sync
  • Nick Hung, Executive Vice President of Technology and Transformation, Deloitte Taiwan